What is CVS stock price today?

CVS (CVS Health Corp) stock is trading at $105.90 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is CVS stock going up or down today?

CVS stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy CVS stock now?

The decision to buy CVS depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is CVS a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for CVS based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is CVS stock overvalued or undervalued?

CVS currently trades at a P/E ratio of 16.26 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if CVS is fairly priced.

What is CVS's P/E ratio?

CVS has a price-to-earnings (P/E) ratio of 16.26, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is CVS's market cap?

CVS (CVS Health Corp) has a market capitalization of $86.20 billion, making it a mid-cap stock.

What is CVS's price to book ratio?

Price-to-book ratio for CVS is available on our dashboard along with other valuation metrics.

Does CVS pay dividends?

Yes, CVS pays dividends with a current yield of 3.90%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is CVS's dividend yield?

CVS's dividend yield is 3.90%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is CVS stock a good long-term investment?

CVS's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is CVS's revenue growth rate?

Revenue growth data for CVS is available on our dashboard with detailed financial statement analysis.

Profitability metrics for CVS are available on our dashboard with complete income statement analysis.

What are the risks of investing in CVS?

Key risks for CVS include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does CVS compare to its competitors?

Compare CVS to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize CVS's performance and positioning.

What is CVS's stock price target for 2026?

Our AI model provides price targets for CVS based on fundamental analysis: Bull case $137.67 (+30%), Base case $121.78 (+15%), Bear case $95.31 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about CVS?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for CVS. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is CVS's next earnings report?

CVS reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

CVS - CVS Health Corp

NYSE * Healthcare * Healthcare Plans

$105.90

+$1.75 (+1.68%)

About CVS Health Corp

CVS Health Corp (CVS) common stock

Price Chart

Loading chart...

CVS Key Statistics

Market Cap

$86.20B

P/E Ratio

16.26

Dividend Yield

3.90%

How CVS Compares to Peers

CVS has the lowest P/E ratio in Healthcare Plans, suggesting it may be the most undervalued

CVS is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
CVS(This stock)	$86.20B	16.3	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 5:53 PM EDT

Ready to invest in CVS?

Commission-free trading available. Affiliate links.

CVS Lician Score

14% confidence

4.0/10

Neutral

CVS has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates CVSacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

CVS Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for CVS

Dashboard

Enter a ticker to analyze